Loading
Loading
Healthcare
Executive compensation benchmarks for 14 public companies in the biological products, (no diagnostic substances) industry.
$15.8M
14
$24.4M
66:1
Median
$15,811,145
Average
$15,199,501
25th Percentile
$10,021,746
75th Percentile
$19,706,283
Minimum
$5,965,903
Maximum
$24,428,495
Avg Pay Ratio
66:1
Companies
14
Click any company to see full compensation breakdown
The median biological products, (no diagnostic substances) CEO compensation is $15,811,145, based on 14 public companies. The average is $15,199,501. Note that CEO compensation includes salary, bonus, stock awards, option awards, and other compensation.
Robert A. Bradway of AMGEN INC is the highest paid biological products, (no diagnostic substances) CEO, with total compensation of $24,428,495 in FY2025.
The average CEO-to-median-employee pay ratio in the biological products, (no diagnostic substances) industry is 66:1. This means the average CEO earns 66 times what the median employee earns.
Data sourced from SEC filings (DEF 14A proxy statements). Last updated: April 15, 2026. Compensation figures are total annual compensation including salary, bonus, stock awards, and other compensation.
Compare CEO compensation across different industries or research specific companies.
| Company | CEO | Total Comp |
|---|---|---|
| AMGEN INC AMGN | Robert A. Bradway | $24.4M |
| GILEAD SCIENCES, INC. GILD | Daniel P. O’Day | $23.7M |
| HALOZYME THERAPEUTICS, INC. HALO | Helen I. Torley | $23.2M |
| REPLIGEN CORP RGEN | Tony J. Hunt | $20.3M |
| Moderna, Inc. MRNA | Stéphane Bancel | $17.9M |
| Vaxcyte, Inc. PCVX | Grant E. Pickering | $16.9M |
| NEUROCRINE BIOSCIENCES INC NBIX | Kevin C. Gorman | $16.0M |
| Krystal Biotech, Inc. KRYS | Krish S. Krishnan | $15.6M |
| EXELIXIS, INC. EXEL | Michael M. Morrissey | $12.7M |
| Revolution Medicines, Inc. RVMD | Mark A. Goldsmith | $10.1M |
| BIOGEN INC. BIIB | C. Viehbacher | $10.0M |
| BIO-TECHNE Corp TECH | Kim Kelderman | $8.2M |
| ARGENX SE ARGX | Tim Van Hauwermeiren | $7.8M |
| Cidara Therapeutics, Inc. CDTX | Jeffrey Stein | $6.0M |